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Abstract
Background: The metabolic syndrome (MS) is a combination of metabolic abnormalities that lead to an increased
risk of cardiovascular diseases. Due to its rising incidence and demanding life-long use of multiple drugs, there is a
growing interest in testing and developing new allopathic, complementary and alternative therapies for controlling
or curing disorders of MS. The discovery of new therapeutic modalities requires animal models of disease and
currently available models have limitations. Developing an appropriate animal model for MS to achieve various
therapeutic targets remains a challenge and this study aims to develop a rat model which closely depicts MS in
humans.
Methodology: Rat model of MS was developed by replacing 60% of diet with fructose. Four groups of
Sprague–Dawley rats were either given whole wheat or refined flour with and without fructose for 8 weeks. Data
were analyzed on SPSS and Graphpad Prism using ANOVA with Tukey’s and Bonferonni tests for multiple group
comparison. A p-value of less than 0.05 was considered significant for differences between groups.
Results: Replacing whole wheat with refined wheat flour in rat chow in 60% fructose-fed Sprague–Dawley rats
resulted in hypertension (p 0.01), hyper-insulinemia (p < 0.001), hyperglycemia (p 0.03) and a reduction in HDL
levels (p 0.002) at 4 weeks while hyper-triglyceridemia (p 0.001) with endothelial dysfunction was observed at
8 weeks.
Conclusion: It is concluded that the refined wheat flour with 60% fructose in diet hastens the development of
metabolic syndrome in 4 weeks and replacing whole wheat flour with refined flour in diet induces a more effective
abnormality including a low HDL. Further studies may be directed to assess the associated pathological changes,
which can be used to study the effect of different therapeutic modalities on an animal model of MS with low HDL.
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Background
The metabolic syndrome (MS) is a combination of certain
metabolic abnormalities such as obesity, insulin resistance,
diabetes, dyslipidemia and hypertension, which in com-
bination are associated with a risk of coronary heart dis-
ease, stroke, and cardiovascular mortality greater than that
of each abnormality [1].
Over the past two decades, the incidence of MS is
rising. According to the Centers for Disease Control
and Prevention, approximately 34% of American adults
meet the criteria for MS [2]. Up to one-fourth of the
European and South Asian adults have MS [3].
Despite the rising incidence, there is limited success to
treat MS with available chemical drugs; hence more
studies are warranted in the search of more efficacious
and safer remedies.
Diet is a major factor in metabolic syndrome [4]. It is
generally recommended that patients with MS should
consume a diet with less saturated fat; increased vegeta-
bles, legumes, fruit and food with a low glycemic index
and high fiber content [5]. There is also an ample evi-
dence that consumption of more refined carbohydrates
than cereal and whole grains is associated with a higher
incidence of Diabetes mellitus [6], dyslipidemia [7], MS
[8] and coronary heart disease (CHD) [9]. Similarly,
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whole grains which include wheat flour bran have not
only been shown to increase the bioavailability of essen-
tial minerals in rats [10] but also have a favorable effect
on diabetic patients [11,12], metabolic markers [13],
CHD [14], ischemic stroke [15] and total mortality [16].
In animal studies, whole grain wheat flour has been
shown to produce metabolic changes, some of which
may protect the organism against oxidative stress [17].
Although a study done two decades back showed favor-
able effects of white flour as compared to whole wheat
flour on cholesterol levels in rats [18] but abundant lit-
erature on humans has clarified the fact that consuming
white flour is associated with dyslipidemia [19].
Drug discovery and development depends on using
animal models of disease before drugs are allowed for
clinical trials. Besides genetic models of MS, such as the
obese Zucker rat, MS is induced in rats through various
protocols, which include administration of sucrose or
fructose in diet. Various studies have shown induction of
features of MS including hyper-triglyceridemia, hyper-
insulinemia, hypertension and hyperglycemia when
Wistar or Sprague–Dawley rats were given 60-66% fruc-
tose for 4–8 weeks [20-22]. A study comparing different
protocols using fructose for induction of MS found that
60% fructose diet is a more effective way for induction
of MS in rats than drinking 10% fructose solution [23].
In these studies, standard rat chow was used which in-
cludes whole wheat flour as a major component. Indu-
cing MS by using existing animal models has limitations
also because it does not induce an abnormality in HDL,
which is an essential component of MS.
Refined or white flour as compared to whole wheat
flour, known to increase postprandial glycemia, is hy-
pothesized to induce signs of metabolic syndrome in rats
more effectively and in a shorter period of time. There-
fore, this study aims to compare the effects of replacing
refined wheat flour with whole wheat flour to diet, in de-
velopment of metabolic syndrome and to see, if it also
induces endothelial dysfunction in fructose fed rats. Al-
though there are ample data on this in human subjects,
but to the best of our knowledge the effect of whole
wheat flour and white flour in induction of MS in rats
has not been compared previously especially the effect
of refined flour in reducing the HDL levels.
Results
The weight gain, fluid and diet intake were similar among
groups at 8 weeks. All other variables were not signifi-
cantly different between groups at baseline (Table 1).
At 4 weeks (Table 2), the BP of whole wheat flour with
fructose (p 0.01) and refined wheat flour with fructose
group was significantly higher than their respective con-
trols (p 0.006). There was no change in serum choles-
terol, TGL, LDL and CRP between groups (p > 0.05).
FBS (p 0.005) while serum insulin level (p < 0.001) was
significantly higher in refined wheat flour with fructose
group. Interestingly, the HDL was significantly lower in
refined wheat flour with fructose as compared to whole
wheat flour with fructose-fed group (p 0.014).
At 8 weeks (Table 3), the BP remained high only in the
fructose-fed refined wheat flour group compared to con-
trol (p 0.008). The FBS and serum insulin levels remained
raised in fructose-fed refined flour group (p < 0.001),
whereas, the whole wheat flour with fructose group al-
though had a raised FBS level than its control (p 0.02),
failed to show a difference in insulin levels (p > 0.05). The
cholesterol levels did not differ significantly between
groups, although the variable as a whole was significant (p
0.049). Due to a significantly low HDL in refined wheat
flour with fructose and without fructose (p <0.001), as
compared to whole wheat flour groups, the total choles-
terol/HDL ratio was significantly raised in refined flour-
fed with (p 0.02) and without fructose groups (p 0.002).
The triglycerides level at 8 weeks was also significantly
higher in refined flour fructose-fed rats than in control
group (p < 0.001).
Figure 1 shows the dose-dependent inhibition of PE
(1 μM)-induced endothelial resistance with ACh in
percentage after a pre-contracted vascular preparation
with intact endothelium. At ACh doses of 0.03 μM and
above, fructose-fed groups with refined wheat and whole
wheat flour were significantly different from each other
(p < 0.001). At ACh doses of 0.3- 100 μM, all the groups
were significantly different from each other (p < 0.001)
except the whole wheat flour and whole wheat flour with
fructose group, which did not show any difference up to
ACh dose of 3 μM.
Discussion
The results of our study show a hastened development of
metabolic syndrome at 4 weeks with the use of refined
wheat flour with 60% fructose in diet. High fasting serum
insulin levels and a raised blood pressure developed and
persisted at 4 weeks and 8 weeks respectively, whereas
cholesterol/HDL ratio and hyper-triglyceridemia were sig-
nificantly raised at 8 weeks. More importantly, there was
evidence of endothelial dysfunction especially in groups
treated with refined flour when the rats were sacrificed at
8 weeks. These results highlight how the use of refined
wheat flour rather than whole wheat flour can negatively
alter the metabolic profile in Sprague–Dawley rats in a
few weeks. This may be due to a protective effect of whole
wheat against oxidative stress, as seen in the past [17,24].
It is also hypothesized that the beneficial effects of whole
grain flour are mediated by an improved insulin sensitiv-
ity, which can be partially explained by the lower glycemic
indices of whole wheat flour in comparison to its fiber-
depleted analog which is refined flour [25].
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The weight, diet and fluid intake was similar among the
groups, which is consistent with other studies reporting
that a 60% fructose without a high fat diet does not lead
to weight gain or adiposity as compared to controls
[26,27]. It is also known from previous studies that obesity
or adipocyte hypertrophy is not the only cause of insulin
resistance/hyper-insulinemia [4]. Studies have shown that
a high fat and high sugar diet can lead to insulin resist-
ance, while defects in the insulin-signaling pathway have
been reported with a high fat diet [28]. There is also report
showing that out of the two aspects of a high fat and sugar
diet, the refined sugar causes greater toxicity than the high
fat content during glucose tolerance tests [29]. Besides,
epidemiological studies revealed that increased consump-
tion of whole grains due to its fiber content is associated
with lower fasting insulin concentrations and glycaemic
response [11].
It is known that high fructose feeding to rats is associ-
ated with oxidative stress and inflammatory response
demonstrated by an increase in reactive oxygen species
production by polymorphonuclear leukocytes and tissues
and an increased plasma levels of IL1 and IL6 [30,31].
C-reactive protein (CRP) is an acute-phase protein se-
creted by the liver and it is used as a marker for subclin-
ical inflammation and CVD risk but the link between CRP
and insulin resistance remains unclear [24]. It is not clear
whether dietary fructose alone can lead to a raised CRP in
rats but dietary fiber intake is shown to be inversely corre-
lated with serum CRP concentration [32]. In our study, al-
though there was no significant difference between CRP
levels among groups (p > 0.05) but CRP was found to be
lower in whole wheat flour-fed group at 8 weeks, although
the difference was insignificant (p > 0.05).
Endothelial dysfunction is also a pro-inflammatory
state [33] and endothelium-dependent relaxation has
been shown to be depressed in fructose-fed animal
models with hypertension [34,35]. Our study showed
similar results with enhanced endotheliopathy in rats,
which were fed with combination of fructose and refined
flour. Moreover, the rats fed on refined wheat flour with
or without fructose had none or less dose-dependent
endothelial relaxation respectively than rats which were
fed whole wheat flour. In humans, whole grain con-
sumption is known to reduce BP [36]. Similarly, in our
Table 1 Comparison of baseline parameters of metabolic syndrome among different groups
Parameters of metabolic
syndrome
Whole wheat flour diet Refined wheat flour diet Fructose and whole wheat
flour diet
Fructose and fefined wheat
flour diet
BP (mmHg) 133 ± 2.86 125 ± 5.9 129 ± 2.23 124 ± 4.49
FBS (mg/dl) 112 ± 5.9 105 ± 6.63 108 ± 5.1 107 ± 9.25
Chol (mg/dl) 68 ± 4.9 58 ± 7.5 60 ± 5.17 58 ± 5.08
TGL (mg/dl) 37 ± 2.38 41 ± 1.8 48 ± 3.78 35 ± 1.54
LDL (mg/dl) 11 ± 1.24 14 ± 1.77 9 ± 0.88 14 ± 2.85
HDL (mg/dl) 58 ± 3.8 65 ± 3.44 54 ± 3.59 66 ± 4.64
CRP (mg/dl) 0.17 ± 0.007 0.12 ± 0.007 0.13 ± 0.008 0.16 ± 0.01
Insulin (ng/dl) 2.5 ± 0.34 2.7 ± 0.59 1.9 ± 0.46 1.4 ± 0.36
Blood pressure (BP), Fasting blood sugar (FBS), Total cholesterol (Chol), Triglycerides (TGL), Low density lipoproteins (LDL), High density lipoproteins (HDL),
C- reactive protein (CRP) and serum insulin expressed as Means ± SEM.
No significant difference was found between groups at p of 0.05.
Table 2 Effect of different diets on parameters of metabolic syndrome at 4 weeks
Parameters of metabolic
syndrome
Whole wheat flour diet Refined wheat flour diet Fructose and whole wheat
flour diet
Fructose and refined wheat
flour diet
BP (mmHg) 136 ± 3.78ab 125 ± 2.65ab 154 ± 3.78c 145 ± 4.54ac
FBS (mg/dl) 95 ± 8.02a 100 ± 12.05a 121 ± 10.9ab 156 ± 10.1b
Chol (mg/dl) 69 ± 5.28a 69 ± 5.97a 67 ± 3.98a 60 ± 2.57a
TGL (mg/dl) 38 ± 2.40a 36 ± 3.87a 38 ± 2.17a 41 ± 3.97a
LDL (mg/dl) 13 ± 1.77a 12 ± 1.91a 16 ± 1.69a 12 ± 1.52a
HDL (mg/dl) 54 ± 4.89a 48 ± 4.57a 60 ± 3.2ab 40 ± 3.39ac
CRP (mg/dl) 0.17 ± 0.018a 0.20 ± 0.014a 0.14 ± 0.01a 0.15 ± 0.01a
Insulin (ng/dl) 3.2 ± 0.54a 4.9 ± 0.84a 2.6 ± 0.49a 14.8 ± 1.87b
Blood pressure (BP), Fasting blood sugar (FBS), Total cholesterol (Chol), Triglycerides (TGL), Low density lipoproteins (LDL), High density lipoproteins (HDL),
C-reactive protein (CRP) and serum insulin expressed as Means ± SEM.
abc Within rows, between control and treated animals, means with different superscript letters differ significantly (p < 0.05).
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study, the protection conferred by whole wheat on blood
pressure at 8 weeks may be due to the high magnesium
content in whole wheat flour, which is known to possess
a calcium antagonist activity [25], in addition to its fiber
content, which also has a role in reduction of blood
pressure [37].
More importantly, previous studies have proposed con-
sumption of a high-carbohydrate, high-fat diet by normal
rodents to be an adequate rodent model to mimic the hu-
man metabolic syndrome and for testing potential thera-
peutic interventions [38]. These studies have shown that
administration of fructose in diet with regular rat chow,
which has whole wheat as a major constituent, leads to an
increase in HDL along with other lipids [23,39]. Even the
Zucker rats, which is a genetic model of metabolic
syndrome has been shown to have an increased HDL,
when fed with a high fat diet [40], which is a major limita-
tion in the development of dyslipidemia. HDL is the pre-
dominant lipoprotein in rats [41,42], thus, it is not worth
exploring changes in LDL levels in rats with different diets
or therapeutic agents.
Fructose with whole wheat chow did not lead to a re-
duction in HDL level probably because whole wheat
flour is already known to have a protective effect on
cholesterols without lowering HDL [43]. Moreover,
among healthy people, a high refined-carbohydrate diet
has been shown to reduce HDL [7]. Keeping in view the
fact that a low HDL level is an essential component of
metabolic syndrome in humans [44] and insulin resist-
ance is strongly associated with a low HDL level [45],
our attempt was to develop a model ensuring an abnor-
mality in HDL levels also.
In this study, a low HDL in the fructose with refined
wheat flour diet also lead to an increase in total choles-
terol/ HDL ratio, which is considered to be an indicator
of an increased risk of coronary heart disease [46].
Besides, this model showed quicker development of fea-
tures of metabolic syndrome at 4 weeks. In previous stud-
ies, the period of fructose administration applied has been
non-standard from 4–8 weeks to several months [23]. Pre-
vious studies have also shown that long-term fructose feed-
ing induces mild insulin resistance without an elevation in
blood pressure [47], which could be due to a protective ef-
fect of whole wheat in rat chow. Also different experimen-
tal designs for fructose administration in rats have shown
to induce variable physiological responses [23].
Conclusion
This study highlights an important finding and proposes a
rat model of metabolic syndrome in 4 weeks with 60%
fructose in diet replacing whole wheat flour with refined
flour as a major constituent. This animal model may bet-
ter translate MS in humans associated with hypertension,







Fructose and whole wheat
flour diet
Fructose and refined wheat
flour diet
BP (mmHg) 133 ± 4.63a 134 ± 4.72a 149 ± 6.98ab 162 ± 5.4b
FBS (mg/dl) 111 ± 5.37a 101 ± 9.0a 149 ± 7.29b 159 ± 11.24b
Chol (mg/dl) 67 ± 2.22a 51 ± 7.24a 68 ± 4.64a 68 ± 2.74a
TGL (mg/dl) 46 ± 4.32ab 47 ± 3.15a 64 ± 11.7ab 65 ± 2.27b
LDL (mg/dl) 13 ± 1.60a 20 ± 1.68b 17 ± 1.58ab 22 ± 1.62b
HDL (mg/dl) 57 ± 3.19a 24 ± 1.64ab 48 ± 4.1a 26 ± 2.85ab
CRP (mg/dl) 0.15 ± 0.01a 0.24 ± 0.03a 0.22 ± 0.02a 0.23 ± 0.02a
Insulin (ng/dl) 3.6 ± 0.54a 7.13 ± 0.76a 7.3 ± 1.45a 16.0 ± 1.86b
Blood pressure (BP), Fasting blood sugar (FBS), Total cholesterol (Chol), Triglycerides (TGL), Low density lipoproteins (LDL), High density lipoproteins (HDL),
C-reactive protein (CRP) and serum insulin expressed as Means ± SEM.




























Figure 1 Comparative effect of different diets on endothelial
function. Comparative effect of different diets on endothelial
function measured in terms of alteration in the Acetylcholine (ACh)
induced vasodilator effect constructed against phenylephrine (PE,
1 μM) induced sustained vascular contraction in rats. A dose
dependent significant difference was seen between refined wheat
with fructose and whole wheat with fructose groups as the ACh
dose was increased from 0.03- 100 μM.
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endothelial dysfunction, hyper-riglyceridemia, insulin re-
sistance and a low HDL, thus offering a better model of
MS. Moreover, this model also allows studying, thera-
peutic effects of test substances on dyslipidemia including
a low HDL level. Further studies are required to study the
pathological changes and to assess the extended effects of
different dietary constituents on MS.
Methods
Handling and use of animals was strictly in accordance
with the Office of Laboratory Animal Welfare policy [48]
and the protocol used in this study was part of PhD pro-
posal of Ms Farida Amin, which was approved by the Aga
Khan University in an open defense held on March 09,
2012. Male Sprague–Dawley rats weighing 150–200 gms,
housed at the Aga Khan University animal house, Karachi
and maintained at 23-25°C were given diet and tap water
ad libitum. The following four groups were made (6 rats/
group): controls on regular diet with whole wheat flour,
controls on regular diet with refined (white) wheat flour,
60% fructose in diet with whole wheat flour and 60% fruc-
tose in diet with refined wheat flour.
The diets of 2 groups which were not fed fructose
contained 60% whole wheat flour or refined wheat flour.
Other constituents were 20% proteins, 15% fats, salt, vi-
tamins, minerals and potassium metabiphosphate. The
diet of the fructose-fed groups contained 60% fructose in
addition to the above diet mixtures after preparation.
Weight and fortnightly Blood Pressures (BP) were mea-
sured by tail cuff method as described previously [49].
Blood was drawn by tail venipuncture. Fasting serum insu-
lin, serum fasting blood sugars (FBS), C-reactive protein
(CRP), serum cholesterol (Chol), low density lipoproteins
(LDL), high density lipoproteins (HDL) and triglycerides
(TGL) were measured at baseline, 4 and 8 weeks of inter-
vention. Tests were performed on Cobas c111 [50-52]. In-
sulin was quantified by ELISA (crystal chemicals) [53]. At
the end of experiment, rats were sacrificed after anesthe-
tizing them with ethyl ether and blood samples at 8 weeks
were drawn by cardiac puncture.
To assess endothelial function, a thoracotomy was
performed after adequate anesthesia, to isolate the descend-
ing thoracic aorta, which was then placed in Kreb’s solution
containing (in mM) NaCl 118.2, NaHCO3 25.0, CaCl2 2.5,
KCl 4.7, KH2PO4 1.3, MgSO4 1.2, glucose 11.7 (pH 7.4)
aerated with a mixture of 95% oxygen and 5% CO2.
In a petri dish, the adherent fat and connective tissue
were gently removed, and the aorta was sectioned into
2-mm segments. The instrument was calibrated and the
aortic segments were mounted on hooks attached to iso-
metric force sensors, and placed into 5 ml temperature
controlled, tissue baths with Krebs’s solution, with a con-
tinuous supply of oxygen. The transducer output was con-
tinuously recorded on a computer with chart pro software
and the vessels were allowed to equilibrate for 45 min.
Then, the arteries were constricted with phenylephrine
(PE1 μM), Sigma, St. Louis, MO and allowed to achieve
maximum constriction. Acetylcholine (ACh) (Sigma) was
then added in incremental log concentrations from 0.01
to 100 μM for determination of endothelium-dependent
relaxation in percentage [54].
Data were analyzed on SPSS version 19.0 and Graphpad
Prism version 5 and expressed as means ± SEM (Standard
error of mean). One way ANOVA was used to compare
the means between groups followed by Tukey’s test for
multiple comparisons. Bonferonni’s test was used to com-
pare endothelial relaxation at different doses of ACh. A
P-value of < 0.05 was considered significant for a differ-
ence between groups.
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